Trial Profile
Toxicological evaluation and antitumoral effect of hR3 monoclonal antibody combined withchemoembolization in metastatic liver treatment.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 13 Oct 2020
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary) ; Fluorouracil (Primary) ; Nimotuzumab (Primary)
- Indications Advanced breast cancer; Colon cancer; Liver metastases
- Focus Therapeutic Use
- 02 Sep 2011 New trial record